These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36104119)

  • 1. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
    Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.
    Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W
    Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
    Nassif MA
    Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry.
    Boneparth A; Ilowite NT;
    Lupus; 2014 Aug; 23(9):898-904. PubMed ID: 24729278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up.
    Farinha F; Pepper RJ; Oliveira DG; McDonnell T; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2020 Nov; 59(11):3314-3323. PubMed ID: 32303057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
    Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
    Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis.
    Nawata A; Nakayamada S; Hisano S; Miyazaki Y; Miyamoto T; Shiba E; Hisaoka M; Tanaka Y
    Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37460249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis.
    Chen S; Zhang X; Meng K; Sun Y; Shu R; Han Y; Feng Q; Li Z; Yang P; Liang J
    Front Immunol; 2023; 14():1077645. PubMed ID: 36845141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family.
    Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N
    Lupus; 2022 Jan; 31(1):55-64. PubMed ID: 34978958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.